Skip to main content

Animations

MJFF Publications

2026 - 2050 of 6420 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2020
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2020
  • 2020
  • 2021
  • 2021
  • 2025
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.024
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.009
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Diagnostic criteria for blepharospasm: A multicenter international study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.004
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central Europe
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.026
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.024
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012
    Citation Count: 19
  • Summary Details
    OPEN
    Title: North American survey on impact of the COVID-19 pandemic shutdown on DBS care
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.011
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scores
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002
    Citation Count: 5
  • Summary Details
    OPEN
    Title: A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.013
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Plasma NfL, clinical subtypes and motor progression in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.016
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.018
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Predicting Parkinson's disease trajectory using clinical and neuroimaging baseline measures
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.026
    Citation Count: 18
  • Summary Details
    OPEN
    Title: White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.031
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.008
    Citation Count: 10
  • Summary Details
    OPEN
    Title: A metabolomic study of cervical dystonia
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.020
    Citation Count: 8
  • Summary Details
    OPEN
    Title: How firms undertake organizational changes to shift to more-exploratory strategies: A process perspective
    Journal Name: Research Policy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.respol.2020.104118
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imaging
    Journal Name: Seminars in Arthritis and Rheumatism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.semarthrit.2021.08.004
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosis
    Journal Name: Sleep Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.sleep.2021.06.005
    Citation Count: 6
  • Summary Details
    OPEN
    Title: LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson’s disease model
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-025-08544-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Criminal Behavior in Frontotemporal Dementia: A Multimodal MRI Study
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/hbm.70308
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Abnormal hyperactivity of specific striatal ensembles encodes distinct dyskinetic behaviors revealed by high-resolution clustering
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.115988
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Bias and Efficiency Comparison Between Multiple Imputation and Available-Case Analysis for Missing Data in Longitudinal Models
    Journal Name: Statistics in Biosciences
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s12561-025-09493-6
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.